187 related articles for article (PubMed ID: 19836067)
21. Limited Role of Promoter Methylation of
Sun LL; Liu Y; Sun X; Pan L; Wu D; Wang YD
Chin Med J (Engl); 2018 Apr; 131(8):939-944. PubMed ID: 29664054
[TBL] [Abstract][Full Text] [Related]
22. CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions.
Chujan S; Kitkumthorn N; Siriangkul S; Mutirangura A
Asian Pac J Cancer Prev; 2014; 15(18):7971-5. PubMed ID: 25292097
[TBL] [Abstract][Full Text] [Related]
23. Gene promoter methylation patterns throughout the process of cervical carcinogenesis.
Yang N; Nijhuis ER; Volders HH; Eijsink JJ; Lendvai A; Zhang B; Hollema H; Schuuring E; Wisman GB; van der Zee AG
Cell Oncol; 2010; 32(1-2):131-43. PubMed ID: 20208141
[TBL] [Abstract][Full Text] [Related]
24. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis.
El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308
[TBL] [Abstract][Full Text] [Related]
25. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
26. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
Lin Z; Gao M; Zhang X; Kim YS; Lee ES; Kim HK; Kim I
J Cancer Res Clin Oncol; 2005 Jun; 131(6):364-70. PubMed ID: 15785933
[TBL] [Abstract][Full Text] [Related]
27. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
28. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
29. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
[TBL] [Abstract][Full Text] [Related]
30. Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis.
Wei Q; Fu B; Liu J; Xu J; Zhao T
Int J Clin Exp Pathol; 2013; 6(8):1549-57. PubMed ID: 23923073
[TBL] [Abstract][Full Text] [Related]
31. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
[TBL] [Abstract][Full Text] [Related]
32. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of candidate methylation markers to detect cervical neoplasia.
Shivapurkar N; Sherman ME; Stastny V; Echebiri C; Rader JS; Nayar R; Bonfiglio TA; Gazdar AF; Wang SS
Gynecol Oncol; 2007 Dec; 107(3):549-53. PubMed ID: 17894941
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
[TBL] [Abstract][Full Text] [Related]
35. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
36. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
37. P16 methylation is an early event in cervical carcinogenesis.
Huang LW; Pan HS; Lin YH; Seow KM; Chen HJ; Hwang JL
Int J Gynecol Cancer; 2011 Apr; 21(3):452-6. PubMed ID: 21436693
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].
Xu J; Wang HL; Lu GC; Wang ZJ; Lin X; Zhou HW
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):394-7. PubMed ID: 17697601
[TBL] [Abstract][Full Text] [Related]
39. Performance of OncoE6
Ndizeye Z; Menon S; Van Geertruyden JP; Sauvaget C; Jacquemyn Y; Bogers JP; Benoy I; Vanden Broeck D
BMJ Open; 2019 Sep; 9(9):e029088. PubMed ID: 31494606
[TBL] [Abstract][Full Text] [Related]
40. Liquid-based cytology: do ancillary techniques enhance detection of epithelial abnormalities?
Mishra S; Husain N; Awasthi NP; Pradeep Y; Roohi R; Saxena S
Arch Gynecol Obstet; 2018 Jul; 298(1):159-169. PubMed ID: 29728850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
